Cardinal Health, Inc. (NYSE:CAH) Given Average Rating of “Moderate Buy” by Brokerages

Cardinal Health, Inc. (NYSE:CAH) has earned a consensus recommendation of “Moderate Buy” from the eighteen brokerages that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $241.80.

A number of research analysts recently weighed in on CAH shares. Citigroup cut their price objective on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Robert W. Baird set a $248.00 price objective on Cardinal Health in a research note on Friday, May 1st. JPMorgan Chase & Co. cut their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Finally, William Blair started coverage on Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock.

Cardinal Health Price Performance

CAH opened at $195.10 on Tuesday. The business has a 50-day moving average of $206.96 and a 200-day moving average of $207.79. Cardinal Health has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The company has a market capitalization of $45.69 billion, a PE ratio of 29.83, a price-to-earnings-growth ratio of 1.16 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same period last year, the business earned $2.35 EPS. The firm’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts expect that Cardinal Health will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 1.1%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CAH. Aventura Private Wealth LLC bought a new position in Cardinal Health in the 4th quarter worth approximately $25,000. University of Texas Texas AM Investment Management Co. bought a new position in Cardinal Health in the 4th quarter worth approximately $26,000. Bank of Jackson Hole Trust bought a new position in Cardinal Health in the 4th quarter worth approximately $27,000. Jones Financial Companies Lllp increased its position in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the period. Finally, Palladiem LLC bought a new position in Cardinal Health in the 4th quarter worth approximately $28,000. 87.17% of the stock is owned by institutional investors.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.